Grays a device whose printed minimum BSA is above the band. Not a device choice. Limits printed as weight, age, sheath size or trial inclusion never gray, and upper limits are not used. Sizes are the “patient size industry recommendation” of ISHLT 2021 Table 1, not label limits. Weight beside BSA: intracorporeal continuous-flow pumps are generally considered above 15–20 kg (smaller implants described); EXCOR is used mostly below 20 kg, from 3 kg. Virtual implantation on imaging is an accepted planning tool for device fit. A grayed device can still be opened.
| Device | Type | Configuration | Flow | Size | Support time (approval) |
|---|---|---|---|---|---|
| Paracorporeal pulsatile, pneumatic | LVAD, RVAD, BiVAD | 0.6–8 L/min | >2.2 kg (smallest patient) | Bridge to transplant (US); also destination (Europe) | |
| Paracorporeal pulsatile, pneumatic | LVAD, RVAD, BiVAD | 0.6–8 L/min | >2.2 kg (smallest patient) | Bridge to transplant (US); also destination (Europe) | |
| Intracorporeal continuous flow | LVAD | up to 10 L/min | ≥1.2 m² (MOMENTUM trial inclusion, not a limit) In December 2020 the FDA approved a labeling update for pediatric uses of the device (PMA P160054/S031); the updated label was not read here, so it is not grayed by BSA. Smallest HeartMate 3 patient in the ACTION registry 17.7 kg, 0.73 m² (Niebler 2024). Shorter inflow than the HVAD (22 vs 32.2 mm, ISHLT 2021). | Bridge to transplant, destination | |
| Paracorporeal continuous flow | LVAD, RVAD, BiVAD | up to 1.5 (PediMag), 10 (CentriMag) L/min | PediMag <20 kg; CentriMag not studied <18 y | PediMag LVAD 6 h (US), 30 d (Europe); CentriMag LVAD 30 d (US, Europe); RVAD 30 d | |
| Adult | Intravascular axial | LVAD | up to 4.3 (CP), >5.5 (5.5) L/min | >1.0 m² (CP), >1.5 m² (5.5) (advisory board) Adult device | 4 d (CP), 14 d (5.5) |
| Pulsatile, replaces both ventricles | Biventricular | up to 7.5 (50 cc), 9.5 (70 cc) L/min | 50 cc >1.2–1.85 m², 70 cc ≥1.7 m²; needs room in the chest | Bridge to transplant (50 cc); also destination (70 cc) | |
| Intracorporeal continuous flow; withdrawn July 2021 | LVAD | 2–10 L/min | ≥1.2 m² | Bridge to transplant, destination |
| Setting | Usual | Source |
|---|---|---|
| Pump size | 10, 15, 25, 30, 50, 60 ml (stroke volume) | FDA SSED |
| Rate | No range printed; a palpable pulse at the set rate | 111522 |
| Systolic pressure (ejection) | LVAD 180–250 mmHg, RVAD 80–150 mmHg (averages) | 111522 |
| Diastolic pressure (suction) | −20 to −40 mmHg | 111522 |
| % systole (time ejecting) | >30% and <50% | 111522 |
| Fill and eject (membrane) | Fill >75%; eject 100% | 111522 |
| Setting | Usual | Source |
|---|---|---|
| Pump size | 10, 15, 25, 30, 50, 60 ml (stroke volume) | FDA SSED |
| Rate | No range printed; a palpable pulse at the set rate | 111522 |
| Systolic pressure (ejection) | LVAD 180–250 mmHg, RVAD 80–150 mmHg (averages) | 070826 |
| Diastolic pressure (suction) | −20 to −70 mmHg | 070826 |
| % systole (time ejecting) | >30% and <50% | 070826 |
| Fill and eject (membrane) | Fill >75%; eject 100% | 111522 |
| Mode | Automatic: the least systolic and diastolic pressure needed to eject and fill. Manual: settings stay until changed; used mainly with the chest open | 070826 |
| Flow alarm | Alarms when the measured flow falls below the threshold you set | 070826 |
Aim: full fill and full ejection every beat (ISHLT 2021). Maximum output = pump volume × rate; actual output is generally less and hard to estimate. To fill better: lower % systole, rate or diastolic pressure, with more systolic pressure so emptying stays full (ISHLT 2021).
MRI contraindicated with an EXCOR (FDA SSED).
Pump rate × pump size / (BSA × 1,000), assuming complete fill and ejection 111522.
Compare ISHLT 2021: rate × pump volume is the maximum output; actual output is generally less and hard to estimate.
Bridge to transplant for children with severe isolated LV or biventricular dysfunction. Contraindicated: unable to take systemic anticoagulation; more than moderate aortic regurgitation that cannot be repaired, or whose repair closes the aortic valve; use as a total artificial heart. Blood chamber and cannulae are transparent, to see deposits and the filling and emptying. Approval study cohorts: BSA <0.7 and 0.7–<1.5 m², weight 3–60 kg. Inpatient only in the US (ISHLT 2021).
Tap the problem. Causes with the expected CVP and cardiac output (CO), then what to do 111522 (algorithm guide p 3) · ACTION algorithm
Wording differs from ISHLT 2021: it says decreasing % systole, rate and diastolic pressure lengthens diastole and improves fill, with more systolic pressure to keep emptying full. With a negative suction value both may mean more suction; neither source says which. Follow the centre’s practice.
Active driver: an S4 alarm means the driver is defective: call the Berlin Heart representative. Changing drivers also moves the batteries and the flow sensor; confirm the settings after 070826. The device-failure steps below are written for the IKUS driver.
ACTION CPR Emergency Algorithms & Care Guide, 2026, p 4 CPR guide · ACTION algorithm
The sheet asks the team to record whether the aortic valve is open or oversewn CPR guide.
Differs from the 2025 algorithm guide algorithms (p 4, closed box below): there, an absent pulse means chest compressions at once; the 2026 guide checks the VAD and hand pumps before CPR. Follow the centre’s code plan.
The EXCOR algorithm guide, written for the IKUS driver algorithms
Tap what failed. Berlin Heart algorithm guide, written for the IKUS driver algorithms (algorithm guide pp 5–8) · ACTION algorithm
One network’s education sheet, not a target: the centre protocol and the device instructions decide. Guideline view: Anticoagulation.
Based on ACTION Learning Network bedside sheets (EXCOR one-page summary 111522; Berlin Heart Emergency Algorithms & Care Guide algorithms; CPR Emergency Algorithms & Care Guide 2026 CPR guide); full sheets at myactioneducation.org (sign-in). Education material, not guidelines: the instructions for use and the centre decide.
Based on ACTION Learning Network bedside sheets (EXCOR Active one-page summary 070826; EXCOR one-page summary 111522; Berlin Heart Emergency Algorithms & Care Guide algorithms; CPR Emergency Algorithms & Care Guide 2026 CPR guide); full sheets at myactioneducation.org (sign-in). Education material, not guidelines: the instructions for use and the centre decide.
| Item | ACTION sheets | ASE 2024 (Adult) |
|---|---|---|
| Speed | The only setting; changed only when connected to the system monitor 10210225 | 3,000–9,000 rpm, usual 4,800–5,600, 100-rpm steps |
| Flow | Estimated from power at the set speed; typical 3–6 L/min 0225 | Estimated, not measured |
| Power | Typical 3–6 W 0225 | Measured; typically <10 W |
| PI | (power max − power min) / power average; typical 3–5 10210225011822 | Range 1–10 |
| Low-flow alarm | Below 2.5 L/min; 2.0 on low-flow controllers 0225 | 2.5 L/min |
ASE 2024: Estep 2024, an adult document.
Aim (ISHLT 2021): optimize preload and afterload; avoid leftward septal shift; if power is off its expected range for the speed, look for thrombosis or malfunction.
Blood pressure: high pressure lowers flow; goals are set by the VAD team; Doppler pressure is recommended even with an arterial line 1021.
Tap the finding. Causes on the sheet 0225, with the guideline beside them (care guide p 3) · ACTION algorithm
Differs from ASE 2024 Adult: a significant drop in PI may mean lower circulating volume; both ACTION sheets list hypovolemia under high PI 10210225.
Differs from ASE 2024 Adult on hypovolemia: there a significant drop in PI may mean lower circulating volume, and a significant rise may mean higher blood pressure.
Adult ASE 2024 also lists inflow obstruction, outflow graft obstruction (twist, kink, thrombus, compression), malignant hypertension and arrhythmia. The alarm: Emergency.
Adult ASE 2024, high flow or power: pump thrombosis, vasodilation, significant aortic regurgitation, LV recovery.
ISHLT 2021: power off its expected range for the speed means looking for thrombosis or malfunction.
ACTION CPR Emergency Algorithms & Care Guide, 2026, p 2 CPR guide · ACTION algorithm
The MAP goal is left blank for the team. The 2025 care guide’s check uses MAP above 60 0225; Adult ISHLT 2023: MAP ≥75 mmHg usually perfuses adequately (I, LOE C). Do not judge perfusion by pulsatility 0225.
The sheet asks the team to record whether the aortic valve is open or oversewn CPR guide.
Differs from the 2025 care guide 0225 (p 6, closed box below): there, a running or restarted pump leads to a re-check of MAP above 60, capillary refill and pump values before CPR; the 2026 guide starts CPR when the pump works but perfusion is inadequate. Follow the centre’s code plan.
HeartMate 3 Algorithms & Care Guide 0225, single-page edition p 6
Adult ISHLT 2023: MAP ≥75 mmHg usually perfuses adequately (I, LOE C). The sheet’s check uses MAP above 60. Do not judge perfusion by pulsatility 0225.
Tap what the controller shows. Red: a hazard, act now 0225 (care guide pp 4–5, 7–10) · ACTION algorithm
One network’s education sheet, not a target: the centre protocol and the device instructions decide. Guideline view: Anticoagulation.
Based on ACTION Learning Network bedside sheets (HeartMate 3 one-page summary 1021; Algorithms & Care Guide 0225; HVAD vs HeartMate 3 011822; CPR Emergency Algorithms & Care Guide 2026 CPR guide); full sheets at myactioneducation.org (sign-in). Education material, not guidelines: the instructions for use and the centre decide.
| Item | PediMag | CentriMag |
|---|---|---|
| Speed | 0–5,500 rpm | 0–5,500 rpm |
| Flow (measured by a flow probe) | 0–1.5 L/min | 0–9.9 L/min |
| High and low flow alarms | Within 20% of target flow | Within 20% of target flow |
| Circuit tubing | 1/4 inch | 3/8 inch |
ISHLT 2021 Table 1 gives flow up to 1.5 L/min (PediMag) and up to 10 L/min (CentriMag).
Blood pressure: little pulsatility; the pump is afterload-sensitive, so keep pressure in range 082423.
Continuous-flow pumps (ISHLT 2021): optimize preload and afterload; avoid leftward septal shift; if power is off its expected range for the speed, look for thrombosis or malfunction.
Tap the problem. Causes, then what to do 082423 · ACTION algorithm
ACTION CPR Emergency Algorithms & Care Guide, 2026, p 3 CPR guide · ACTION algorithm
Temporary cannulae: CPR only at the code leader’s discretion CPR guide.
The sheet asks the team to record whether the aortic valve is open or oversewn CPR guide.
No guideline CPR class for temporary pumps is shown here.
The PediMag and CentriMag sheet prints no regimen: the centre protocol decides. Guideline view: Anticoagulation.
Based on ACTION Learning Network bedside sheets (PediMag & CentriMag one-page summary 082423; CPR Emergency Algorithms & Care Guide 2026 CPR guide); full sheets at myactioneducation.org (sign-in). Education material, not guidelines: the instructions for use and the centre decide.
Adult devices Size limits are adult advisory-board thresholds (ISHLT 2021).
| Item | Impella CP | Impella 5.5 |
|---|---|---|
| Mean flow at P-9 | 3.3–3.6 L/min 0425; 3.3–3.7 202509 | 5.0–5.5 L/min 0425202509 |
| Maximum flow (ISHLT 2021) | up to 4.3 L/min | >5.5 L/min |
| Minimum vessel diameter | 5 mm 0425 | 7 mm 0425 |
| Largest pump diameter | 14 Fr 202509 | 21 Fr 202509 |
| Inlet below the aortic valve | 3.5 cm 202509 | 5 cm 202509 |
Use the lowest P-level (P-2 or higher) that gives the flow needed 202509. The two sheets differ on CP at P-9 (3.6 vs 3.7 L/min). Purge (set by the device): pressure 300–1,100 mmHg, flow 2–30 ml/h 202509.
38 patients (39 implants), 16 centres, 2009–15; median age 16 y (4–21), weight 62 kg (15–134); support 45 h (1–1224). Survival 85% at 7 d, 68% at 30 d. Major events: hemolysis 3, bleeding 2, stroke 1, sepsis 1, critical leg ischemia 1; more aortic regurgitation in 3 (Dimas 2017).
Tap the problem. Steps in order 202509 · ACTION algorithm
ACTION CPR Emergency Algorithms & Care Guide, 2026, p 5 CPR guide · ACTION algorithm
Whenever it restarts: echo for position and RV failure; discuss replacing the pump 202509.
Steps 0425. No guideline CPR class for the Impella is shown here.
One network’s education sheets, not targets: the centre protocol and the device instructions decide. Guideline view: Anticoagulation.
Based on ACTION Learning Network bedside sheets (Impella one-page summary IMP-6211 0425; Algorithms & Care Guide 202509 IMP 6676v2, co-branded with the manufacturer; CPR Emergency Algorithms & Care Guide 2026 CPR guide); full sheets at myactioneducation.org (sign-in). Education material, not guidelines: the instructions for use and the centre decide.
| Setting | Typical |
|---|---|
| Rate | 125 ± 15 /min |
| Drive pressure | Left 180–210 mmHg, right 80–100 mmHg |
| Vacuum | Left 0 to −13 mmHg, right 0 to −10 mmHg (left usually more) |
| % systole | 50 ± 5% |
| Fill and eject | Full eject, partial fill; goal fill 50–60 ml (70 cc), 30–40 ml (50 cc) |
Blood pressure below 135 mmHg (afterload-sensitive); a palpable pulse at the set rate 02102023.
Size: the sheet uses 70 cc above 1.7 m², 50 cc at or below 02102023. ISHLT 2021 Table 1: 50 cc >1.2–1.85 m², 70 cc ≥1.7 m² (its text: 50 cc below 1.5 m²). Adult ISHLT 2023: 50 cc for BSA ≤1.7 m², 70 cc for ≥1.7 m² (IIa, LOE A); no guideline gives a minimum chest size; chest CT for fit before any TAH (I, LOE C).
Tap the problem 02102023 · ACTION algorithm
One network’s education sheet, not a target: the centre protocol and the device instructions decide. Guideline view: Anticoagulation.
Based on the ACTION Learning Network bedside sheet (SynCardia one-page summary 02102023); full sheets at myactioneducation.org (sign-in). Education material, not guidelines: the instructions for use and the centre decide.
Removed from the market in July 2021 after adult outcomes. Our note: for settings, follow the implanting centre’s device team.
Continuous-flow pumps (ISHLT 2021): optimize preload and afterload; avoid leftward septal shift; if power is off its expected range for the speed, look for thrombosis or malfunction.
Intracorporeal continuous-flow (centrifugal, ISHLT 2021 text) LVAD, 2–10 L/min, ≥1.2 m² (ISHLT 2021 Table 1). In the ACTION registry 187 children had one, the smallest 10.1 kg and 0.45 m²; 7 were still on it in April 2023 (Niebler 2024).
Based on the ACTION Learning Network bedside sheet (HVAD vs HeartMate 3 011822); full sheets at myactioneducation.org (sign-in). Education material, not guidelines: the instructions for use and the centre decide.
Our diagrams, from the text of ISHLT 2021: which circulation each pump takes over; boxes, not anatomy. LVAD or BiVAD applies only to biventricular circulations; a total artificial heart replaces both ventricles.
| Device | Type | Configuration | Flow | Size | Support time (approval) |
|---|---|---|---|---|---|
| RotaFlow | Paracorporeal continuous flow | LVAD, RVAD, BiVAD | up to 10 L/min | All | 6 h (US); up to 30 d (Europe) |
| PediMag US pediatric indication | Paracorporeal continuous flow | LVAD, RVAD, BiVAD | up to 1.5 L/min | <20 kg | LVAD 6 h (US), 30 d (Europe); RVAD 30 d |
| CentriMag | Paracorporeal continuous flow | LVAD, RVAD, BiVAD | up to 10 L/min | Not studied <18 y | LVAD 30 d (US, Europe); RVAD 30 d |
| TandemHeart | Paracorporeal continuous flow | LVAD, RVAD, BiVAD | up to 5 L/min | >1.3 m² Adult device | 6 h |
| Protek Duo | Paracorporeal continuous flow | RVAD | up to 4.5 L/min | Needs a 29 F sheath Adult device | 6 h |
| Impella 2.5, CP | Intravascular axial | LVAD | up to 2.5 (2.5), 4.3 (CP) L/min | >1.0 m² (advisory board) Adult device | 4 d |
| Impella 5.0, 5.5 | Intravascular axial | LVAD | up to 5.0 (5.0), >5.5 (5.5) L/min | >1.5 m² (advisory board) Adult device | 14 d |
| Impella RP | Intravascular axial | RVAD | up to 4.0 L/min | >1.5 m² Adult device | 14 d |
| Device | Type | Configuration | Flow | Size | Approval |
|---|---|---|---|---|---|
| Berlin Heart EXCOR US pediatric indication | Paracorporeal pulsatile, pneumatic | LVAD, RVAD, BiVAD | 0.6–8 L/min | >2.2 kg (smallest patient) | Bridge to transplant (US); also destination (Europe) |
| HeartMate 3 | Intracorporeal continuous flow | LVAD | up to 10 L/min | ≥1.2 m² (MOMENTUM trial inclusion, not a limit) | Bridge to transplant, destination |
| HVAD | Intracorporeal continuous flow; withdrawn July 2021 | LVAD | 2–10 L/min | ≥1.2 m² | Bridge to transplant, destination |
| SynCardia TAH 50 cc US pediatric indication | Pulsatile, replaces both ventricles | Biventricular | up to 7.5 L/min | >1.2–1.85 m²; needs room in the chest ISHLT 2021 text gives BSA <1.5 m² for the 50 cc device. ISHLT 2023 (adult guideline): 50 cc for BSA ≤1.7 m², 70 cc for ≥1.7 m² (IIa, A); no guideline gives a minimum chest size; chest CT for fit before any TAH (I, C). | Bridge to transplant |
| SynCardia TAH 70 cc | Pulsatile, replaces both ventricles | Biventricular | up to 9.5 L/min | ≥1.7 m²; needs room in the chest | Bridge to transplant, destination |
| Jarvik 2015 (investigational) | Intracorporeal axial | Not printed | 0.5–3 L/min | Study cohort 8–30 kg | No approval; trial ongoing at the time of the table |
Check LA and LV decompression, aortic valve opening, septum (keep it midline), RV size, TR, cannula position. In small children beware over-decompression and leftward septal shift (ACTION 2025).
Biventricular circulation only. One hemodynamic and one imaging finding, more than 72 h after the operation, with no device malfunction or thrombus. Hemodynamic: right-sided or systemic venous pressure >14 mmHg for >24 h, or clinical high venous pressure (effusions, ascites, hepatomegaly) with poor LVAD preload (calculated output <50% of expected, not helped by pump changes). Imaging: more than moderate/severe TR, or more than moderately/severely reduced RV function (as printed). Or: ECMO for right-sided failure, or an RVAD, at any time. Medical-only cases count after 10 days (ACTION-ARC 2023). Adult early RV failure (ISHLT 2021): inotropes >14 d, inhaled NO >48 h or unplanned RVAD. Early elective RVAD is linked to better outcomes than late emergent support (ISHLT 2021).
| Event | Definition | At the bedside (ISHLT 2021) |
|---|---|---|
| Hemolysis | Any of, on 2 consecutive draws: plasma free Hb >50 mg/dl; LDH >3× the centre’s upper limit, no other cause; moderate or more hemolysed cells on smear | LDH is the most sensitive marker |
| Pump thrombus | Pump or part exchanged for thrombus Paracorporeal or transcatheter devices: a pump or component exchanged for thrombus or fibrin. Intracorporeal: exchange for at least 2 of unexpected parameter change, inadequate support or embolism, hemolysis, and thrombus confirmed on explant or imaging (ACTION-ARC 2023). | Inspect an EXCOR chamber; rising LDH: heparin or bivalirudin first One approach in ISHLT 2021: heparin or bivalirudin for rising LDH; if LDH keeps rising with pump parameter changes, some centres consider low-dose systemic tPA when there is no contraindication; pump exchange if tPA is contraindicated, progression is rapid or there is no response. Some centres exchange without a trial of tPA. |
| Stroke | Overt or covert neurological event; severity by change in PCPC | Non-contrast head CT within 30 min CT angiogram if the CT is negative and symptoms persist; thrombectomy or IV tPA may be options for a large-vessel occlusion; with a paracorporeal pump, consider exchange if there is clot. Small hemorrhage without deficits: hold antithrombotics, resume when imaging and examination are stable; expanding or large hemorrhage: hold and consider reversal, restart timing decided by the team (ISHLT 2021, ACTION stroke bundle). |
Monitoring: heparin by aPTT or anti-Xa; LMWH by anti-Xa; warfarin by INR; bivalirudin by aPTT and dilute thrombin time. Start anticoagulation only once hemostasis is achieved. Neonatal procoagulant factors are about 50% of adult levels; antithrombin, protein C and protein S are lower and fibrinolysis is reduced, so heparin is hard to titrate and adult protocols do not transfer. Milrinone, nitroprusside and inhaled NO inhibit platelets; VerifyNow and PFA-100 are not validated in children, and TEG platelet mapping tracks dose less well than once thought. Fever, high CRP or fibrinogen may prompt a change in anticoagulation or steroids; small studies suggest steroids may lower stroke on EXCOR (ISHLT 2021). Lesion-by-lesion targets: Antithrombotic Therapy.
Why regimens differ, one example: in single-centre before-and-after EXCOR cohorts (2009–14, 27 children), moving from two antiplatelet drugs titrated to TEG/PlateletMapping (Edmonton guideline) to three antiplatelet drugs uptitrated to high weight-based targets, with low-dose steroids for inflammation, was associated with 84% fewer strokes (0.8 vs 4.9 per 1,000 days of support) and less bleeding (Rosenthal 2017).
| Profile | Description | Support | Pediatric implants |
|---|---|---|---|
| 1 | Critical cardiogenic shock | Immediate MCS (temporary or durable) | 30.4% |
| 2 | Progressive decline on inotropes | Once stabilized, consider a durable VAD | 55.4% |
| 3 | Stable but inotrope-dependent | Durable MCS, planned electively | 11.1% |
| 4–7 | Increasingly stable | Medical management | 2.4% |
| Strength | Recommendation |
|---|---|
| Strong, very low certainty | In medically unresponsive acute HF (profile ≥2), implant a VAD before cardiogenic shock rather than wait for profile 1 (rec 8) |
| Conditional, very low certainty | Temporary MCS (centrifugal or percutaneous axial pump) over VA-ECMO, in centres with VAD programmes; lung disease may need ECMO first (rec 9) 13 observational studies; in-hospital mortality with a VAD vs VA-ECMO OR 0.51 (95% CI 0.29–0.90). |
| Conditional, low certainty | Left heart decompression within 24 h on VA-ECMO (rec 10) |
VA-ECMO, for comparison: CCS/CPCA 2026 suggests temporary MCS over VA-ECMO in acute heart failure (rec 9 above).
Devices, settings, troubleshooting and timing for children; Adult values labelled Adult.
ACTION (Advanced Cardiac Therapies Improving Outcomes Network) bedside sheets from myactioneducation.org (sign-in needed), read 10 November 2026. Code = the number printed at the foot of each sheet. They are teaching material from a pediatric network; their typical ranges state no population. Each device screen draws on that device’s sheets only, tags each item with its sheet code, and ends by naming them; a guideline that differs is shown beside the item. Tag “algorithms” = the Berlin Heart Emergency Algorithms & Care Guide, which prints no code. “ACTION algorithm” links go to the sheet finder page. Sheet titles are as printed; “one-page summary” is ACTION’s name for the series on its site, not printed on the sheets.